slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 89,611-89,640
Pages 3,683
Rows per page 30
Component
89,611-89,640 of 110,471
05
The slide uses stacked bar charts to show revenue composition over three fiscal periods (Q1 FY22-FY24).Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
07
The slide uses a color-coded matrix to categorize games and a timeline-based list for FY24 releases.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
08
The slide uses a split-screen layout: left side focuses on the brand ecosystem and community scale, right side focuses on product features and partnerships.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
10
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
Includes sensitivity analysis for USD strengthening against various currencies.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The chart displays 69 projects as individual data points, with horizontal reference lines for average ROI and break-even point.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
17
The forecast range is SEK 7,000 – 9,000 million.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
21
The slide uses a horizontal bar chart style to represent a phased timeline.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a card-based layout to display five key executives with their titles and previous company affiliations.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
14
The slide uses a biological process diagram to illustrate the mechanism of immune activation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
32
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
35
The slide uses a comparative diagram to illustrate the selective mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
43
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
10
The slide uses a process flow framework to explain revenue recognition and cash collection timing.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
12
The slide uses a waterfall-style comparison for Revenue and COGS to emphasize year-over-year changes.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
13
The slide illustrates a structural biology approach to drug design, focusing on helix-receptor interactions and sequence engineering.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
15
The slide uses a visual comparison framework to illustrate the mechanism of action and therapeutic benefits.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
20
Includes comparative data against Mogamulizumab (MAVORIC trial) and visual evidence of skin improvement.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Uses a contrast-based framing (750k patients vs 0 drugs) to establish market opportunity.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
Swimmer plot visualization of clinical trial data.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
24
The slide uses a biological signaling pathway map to justify combination therapy strategy.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
27
The diagram shows the signaling pathway with specific drug targets highlighted.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
28
Data shows tumor volume over time for various treatment groups including monotherapy and combinations.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
29
Includes waterfall plot (left) and swimmer plot (right) with specific response rates and disease control rates.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
30
Data cut 23MAR2023. Table shows frequency of specific adverse events by severity grade and dosage cohort.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
33
Data presented as tumor volume over time (days) with error bars representing SEM.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
47
The slide uses a contrast-based layout to frame the subject as a winner in a difficult therapeutic space.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
50
The chart displays individual patient responses categorized by dose level, with a list of specific notable responses on the right.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit